AMRN FY 2020 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$614M+42.9% YoY

Gross Profit

$483M78.6% margin

Operating Income

-$20M-3.2% margin

Net Income

-$18M-2.9% margin

EPS (Diluted)

$-1.00

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$966M

Total Liabilities

$339M

Stockholders' Equity

$628M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$614M	$430M	+42.9%
Gross Profit	$483M	$334M	+44.6%
Operating Income	-$20M	-$24M	+19.0%
Net Income	-$18M	-$23M	+20.5%